|
Total number of patients (%)
|
101 (100)
|
67 (66.3)
|
34 (33.7)
| |
|
STEMI, no (%)
|
91 (90.1)
|
58 (57.4)
|
33 (32.7)
|
0.158
|
|
MI territory
|
|
Anterior, no (%)
|
61 (61.0)
|
42 (42.0)
|
19 (19.0)
|
0.667
|
|
Inferior, no (%)
|
38 (38.0)
|
26 (26.0)
|
12 (12.0)
|
1.000
|
|
Lateral, no (%)
|
32 (32.0)
|
22 (22.0)
|
10 (10.0)
|
1.000
|
|
RV involvement, no (%)
|
5 (5.0)
|
1 (1.0)
|
4 (4.0)
|
0.040
|
|
Peak troponin, ng/L med (IQR)
|
38.9 (13.7–40.0)
|
26.8 (10.9–40.0)
|
40.0 (19.1–626.0)
|
0.146
|
|
LV systolic function
|
|
Normal, no (%)
|
10 (11.6)
|
8 (9.3)
|
2 (2.3)
|
0.488
|
|
Mild dysfunction, no (%)
|
26 (30.2)
|
21 (24.4)
|
5 (5.8)
|
0.093
|
|
Moderate dysfunction, no (%)
|
22 (25.6)
|
17 (19.8)
|
5 (5.8)
|
0.309
|
|
Severe dysfunction, no (%)
|
28 (32.6)
|
14 (16.3)
|
14 (16.3)
|
0.037
|
|
Thrombolysis pre-PPCI, no (%)
|
1 (1.0)
|
1 (1.0)
|
0 (0.0)
|
1.000
|
|
Angiogram, (successful completion) no (%)
|
99 (98.0)
|
67 (66.3)
|
32 (31.7)
|
0.111
|
|
PCI performed (successful completion), no (%)
|
91 (90.1)
|
62 (61.4)
|
29 (28.7)
|
0.298
|
|
IABP in cath lab, no (%)
|
50 (49.5)
|
28 (27.7)
|
22 (21.8)
|
0.036
|
|
Number of diseased vessels, med (IQR)
|
2 (1–3)
|
2 (1–3)
|
2 (2–3)
|
0.514
|
|
Left main stem disease, no (%)
|
14 (14.1)
|
8 (8.1)
|
6 (6.1)
|
0.371
|
|
TIMI flow, med (IQR)
|
3 (2–3)
|
3 (2–3)
|
3 (2–3)
|
0.862
|
|
Symptom onset to device time (min, med (IQR)
|
210 (155–332)
|
219 (159–328)
|
200 (150–350)
|
0.665
|
